Pfizer CEO discusses the company’s GLP-1 weigh-loss drug pipeline


Pfizer (PFE) chairman and CEO Albert Bourla joins Julie Hyman on Market Domination to talk more about the pharmaceutical giant’s progress in developing a GLP-1 weight-loss drug and its current injectable product portfolio.

Also catch Yahoo Finance’s full interview with Albert Bourla.

To watch more expert insights and analysis on the latest market action, check out more Market Domination.



Source link

  • Related Posts

    White House holds press briefing

    IE 11 is not supported. For an optimal experience visit our site on another browser. UP NEXT Timothy Busfield indicted on child sex abuse charges by New Mexico grand jury…

    Syria and Saudi Arabia sign multibillion-dollar investment deals to boost economy

    DAMASCUS, Syria (AP) — Syria and Saudi Arabia signed multibillion-dollar investment agreements on Saturday, including a major telecommunications project, a low-cost joint airline and an international airport in northern Syria.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    5 French-Girl Spring 2026 Microtrends to Note, According to a Fashion Editor Living in Paris

    5 French-Girl Spring 2026 Microtrends to Note, According to a Fashion Editor Living in Paris

    Nithya Raman Announces She Will Run for Los Angeles Mayor

    Scientists find a missing link between Epstein-Barr virus and multiple sclerosis

    Scientists find a missing link between Epstein-Barr virus and multiple sclerosis

    HBO’s Baldur’s Gate Show Wants To Be a Sequel to BG3. That’s Impossible.

    HBO’s Baldur’s Gate Show Wants To Be a Sequel to BG3. That’s Impossible.

    Saudis Announce New Investments in Syria, a Sign of Deepening Ties

    NSA detected phone call between foreign intelligence and a person close to Trump | US national security

    NSA detected phone call between foreign intelligence and a person close to Trump | US national security